The recruitment triangle: Reasons why African Americans enroll, refuse to enroll, or voluntarily withdraw from a clinical trial: An Interim Report from the African-American Antiplatelet Stroke Prevention Study (AAASPS)

Journal of the National Medical Association

Volumn 90, Issue 3, 1998, Pages 141-145

  Gorelick, Philip B ^a,b   Harris, Yvonne ^a   Burnett, Barbara ^a   Bonecutter, Faith J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Center for Stroke Research   (United States)

Author keywords

African Americans; Clinical trials; Recruitment

Indexed keywords

ANTITHROMBOCYTIC AGENT;

AFRICAN AMERICAN; AFRICAN-AMERICAN ANTIPLATELET STROKE PREVENTION STUDY; ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; EMPIRICAL APPROACH; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MIDDLE AGED; PATIENT; PATIENT SELECTION; PROFESSIONAL PATIENT RELATIONSHIP; PSYCHOLOGICAL ASPECT; RESEARCH SUBJECT; TRUST; UNITED STATES;

AFRICAN-AMERICAN ANTIPLATELET STROKE PREVENTION STUDY; BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH; PROFESSIONAL PATIENT RELATIONSHIP;

AFRICAN AMERICANS; CEREBROVASCULAR DISORDERS; CLINICAL TRIALS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT DROPOUTS; PATIENT SELECTION; PLATELET AGGREGATION INHIBITORS; RESEARCH SUBJECTS; THERAPEUTIC HUMAN EXPERIMENTATION; TRUST; UNITED STATES;

EID: 0032019516     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Harris Y, Gorelick PB, Samuels P, Bempong I. Why African Americans may not be participating in clinical trials. J Natl Med Assoc. 1996;88:630-634.
2. Gorelick PB, Richardson D, Hudson E, Perry C, Robinson D, Brown N, et al. Establishing a community network for recruitment of African Americans into a clinical trial. The African-American Antiplatelet Stroke Prevention Study (AAASPS) Experience. J Natl Med Assoc. 1996;88:701-704.
3. Underwood S, Sanders E, Davis M. Determinants of participation in state-of-the-art cancer prevention, early detection/screening and treatment trials among African-Americans. Cancer Nurs. 1993;16:25-33.
4. Allen A. The dilemma of women of color in clinical trials. J Am Med Wom Assoc. 1994;49:105-109.
5. Thomas C, Pinto H, Roach M, Vaughn C. Participation in clinical trials: is it state-of-the-art treatment for African Americans and other people of color? J Natl Med Assoc. 1994;86:177-181.
6. Gavaghan H. Clinical trials face lack of minority group volunteers. Nature. 1995;373:178.
7. Stoy D, Curtis RC, Dameworth KS, Dowdy AA, Hegland J, Levin JA, et al. The successful recruitment of elderly black subjects in a clinical trial: the CRISP experience. J Natl Med Assoc. 1995;87:280-287.
8. Swanson GM, Ward AJ. Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst. 1995;87:1747-1759.
9. Blendon RJ, Aiken LH, Freeman HE, Corey CR. Access to medical care for black and white Americans. JAMA. 1989;261:278-282.
10. Council of Ethical and Judicial Affairs. Black-white disparities in health care. JAMA. 1990;263:2344-2346.
11. Svensson C. Representation of American blacks in clinical trials of new drugs. JAMA. 1989;261:263-265.
12. Savitt T. The use of blacks for medical experimentation and demonstration in the old South. Journal of Southern History. 1982;28:331-348.
13. Garet W. Racism and sexism in medical care. Soc Org Med Care. 1978;267-271.
14. Caplan A, Edgar H, King P. Twenty years later: the legacy of the Tuskegee Syphilis Study. Hastings Cent Rep. 1992;22:29-38.
15. Pinn V. The role of the NIH's Office of Research on Women's Health. Acad Med. 1994;69:698-702.
16. Roberson N. Clinical trial participation: viewpoints from racial/ethnic groups. Cancer. 1994;74:2687-2691.
17. Eighteenth World Medical Assembly. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA. 1997;277:925-934.
18. Vertch RM. Consent, confidentiality, and research. N Engl J Med. 1997;336:869-870.